Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yutong Xing

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
International Journal of Pharmaceutics|April 29, 2021
Preclinical evaluation of a novel anti-mesothelin immunotoxin based on a single domain antibody as the targeting ligandQiyu Li, Wenjing Li, Keyuan Xu, et al.
International Journal of Molecular Sciences|June 2, 2021
A Single-Domain Antibody-Based Anti-PSMA Recombinant Immunotoxin Exhibits Specificity and Efficacy for Prostate Cancer TherapyYutong Xing, Keyuan Xu, Shixiong Li, et al.
Anticancer Research|May 5, 2005
MCI-186 inhibits tumor growth through suppression of EGFR phosphorylation and cell cycle arrestRyoko Suzuki, Rajesh Katare Gopalrao, Hironori Maeda, et al.
Molecular Pharmaceutics|March 6, 2018
cRGD Peptide-Conjugated Pyropheophorbide-a Photosensitizers for Tumor Targeting in Photodynamic TherapyWenjing Li, Sihai Tan, Yutong Xing, et al.
Open Forum Infectious Diseases|January 12, 2026
Neurological Manifestations and High Viral Load as Independent Predictors of Mortality in Severe Fever With Thrombocytopenia SyndromeRujia Chen, Yutong Xing, Wei Wei, et al.
Journal of Cellular Physiology|February 19, 2024
m<sup>6</sup>A-induced TRIB3 regulates Hippo pathway through interacting with LATS1 to promote the progression of lung adenocarcinomaJiamei Wu, Tingzhuang Yi, Chenyi Zhuo, et al.
Diabetes, Obesity & Metabolism|March 27, 2025
Associations of body roundness index with cardiovascular disease and mortality among patients with metabolic syndromeZiqi Chen, Iokfai Cheang, Xu Zhu, et al.
Asian Journal of Pharmaceutical Sciences|June 22, 2026
Chimeric biohybrid nanovesicles induce immunogenic cell death for targeted and immune-potentiated glioblastoma therapyXiaojing Zhu, Yutong Xing, Wenrui Jin, et al.
International Journal of Pharmaceutics|December 15, 2019
HER2-specific immunotoxins constructed based on single-domain antibodies and the improved toxin PE24X7Li Cao, Qiyu Li, Zhen Tong, et al.
BMC Cancer|July 18, 2024
Immunological profiling for short-term predictive analysis in PD-1/PD-L1 therapy for lung cancerYun Wang, Rujia Chen, Zhenzhou Guo, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
International Journal of Pharmaceutics|April 29, 2021
Preclinical evaluation of a novel anti-mesothelin immunotoxin based on a single domain antibody as the targeting ligandQiyu Li, Wenjing Li, Keyuan Xu, et al.
International Journal of Molecular Sciences|June 2, 2021
A Single-Domain Antibody-Based Anti-PSMA Recombinant Immunotoxin Exhibits Specificity and Efficacy for Prostate Cancer TherapyYutong Xing, Keyuan Xu, Shixiong Li, et al.
Anticancer Research|May 5, 2005
MCI-186 inhibits tumor growth through suppression of EGFR phosphorylation and cell cycle arrestRyoko Suzuki, Rajesh Katare Gopalrao, Hironori Maeda, et al.
Molecular Pharmaceutics|March 6, 2018
cRGD Peptide-Conjugated Pyropheophorbide-a Photosensitizers for Tumor Targeting in Photodynamic TherapyWenjing Li, Sihai Tan, Yutong Xing, et al.
Open Forum Infectious Diseases|January 12, 2026
Neurological Manifestations and High Viral Load as Independent Predictors of Mortality in Severe Fever With Thrombocytopenia SyndromeRujia Chen, Yutong Xing, Wei Wei, et al.
Journal of Cellular Physiology|February 19, 2024
m<sup>6</sup>A-induced TRIB3 regulates Hippo pathway through interacting with LATS1 to promote the progression of lung adenocarcinomaJiamei Wu, Tingzhuang Yi, Chenyi Zhuo, et al.
Diabetes, Obesity & Metabolism|March 27, 2025
Associations of body roundness index with cardiovascular disease and mortality among patients with metabolic syndromeZiqi Chen, Iokfai Cheang, Xu Zhu, et al.
Asian Journal of Pharmaceutical Sciences|June 22, 2026
Chimeric biohybrid nanovesicles induce immunogenic cell death for targeted and immune-potentiated glioblastoma therapyXiaojing Zhu, Yutong Xing, Wenrui Jin, et al.
International Journal of Pharmaceutics|December 15, 2019
HER2-specific immunotoxins constructed based on single-domain antibodies and the improved toxin PE24X7Li Cao, Qiyu Li, Zhen Tong, et al.
BMC Cancer|July 18, 2024
Immunological profiling for short-term predictive analysis in PD-1/PD-L1 therapy for lung cancerYun Wang, Rujia Chen, Zhenzhou Guo, et al.
Pageof 4